All news

NewAmsterdam grants 71,800 options at $24.16 to seven hires

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

NewAmsterdam Pharma (NAMS) has granted inducement share options for 71,800 ordinary shares to seven new non-executive hires, with an exercise price of $24.16 per share, matching the closing price on October 1, 2026. These options vest over four years. Additionally, 17,745 restricted stock units were granted to the same new hires, vesting in equal thirds over three years.

Read original source

NAMS company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.